Index test:GFAP, pTau-217, NfL, Aß1-42 and APOE e4

2 trials

Sponsors

Huashan Hospital, Fudan University

Conditions

Subjective cognitive decline

Unknown Phase

Clinical Feasibility of Blood Biomarkers for Early and Differential Diagnosis of Alzheimer’s Disease in a Prospective Cohort

Active, not recruitingChiCTR2400094088

Huashan Hospital, Fudan UniversitySubjective cognitive decline

Start: 2025-01-01Updated: 2025-01-06

Clinical Feasibility of Blood Biomarkers for Early and Differential Diagnosis of Alzheimer’s Disease in a Retrospective Cohort

Active, not recruitingChiCTR2500100597

Huashan Hospital, Fudan UniversitySubjective cognitive decline

Start: 2025-04-21Updated: 2025-04-14